Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

961 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable Pancreatic Cancer: A Retrospective Study.
Suto H, Fuke T, Matsukawa H, Ando Y, Oshima M, Nagao M, Takahashi S, Shibata T, Yamana H, Kamada H, Kobara H, Okuyama H, Kumamoto K, Okano K. Suto H, et al. Among authors: okano k. J Clin Med. 2024 Feb 21;13(5):1216. doi: 10.3390/jcm13051216. J Clin Med. 2024. PMID: 38592055 Free PMC article.
Predictive role of the prognostic nutritional index in patients with pancreatic ductal adenocarcinoma who underwent neoadjuvant chemoradiotherapy followed by curative pancreatic resection: A retrospective study using prospectively collected data.
Suto H, Matsukawa H, Ando Y, Oshima M, Fuke T, Nagao M, Yamana H, Kamada H, Kumamoto K, Okano K. Suto H, et al. Among authors: okano k. J Hepatobiliary Pancreat Sci. 2024 Mar 10. doi: 10.1002/jhbp.1424. Online ahead of print. J Hepatobiliary Pancreat Sci. 2024. PMID: 38462668
Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study.
Suto H, Matsukawa H, Fuke T, Nagao M, Ando Y, Oshima M, Yamana H, Kamada H, Kobara H, Okuyama H, Kumamoto K, Okano K. Suto H, et al. Among authors: okano k. Pancreatology. 2024 May;24(3):431-436. doi: 10.1016/j.pan.2024.02.007. Epub 2024 Feb 16. Pancreatology. 2024. PMID: 38383175
Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Ductal Adenocarcinoma.
Nagao M, Oshima M, Suto H, Sugimoto M, Enomoto A, Murakami T, Shimomura A, Wada Y, Matsukawa H, Ando Y, Kishino T, Kumamoto K, Kobara H, Kamada H, Masaki T, Soga T, Okano K. Nagao M, et al. Among authors: okano k. Pancreas. 2024 Apr 1;53(4):e301-e309. doi: 10.1097/MPA.0000000000002304. Epub 2024 Feb 20. Pancreas. 2024. PMID: 38373081
961 results